INSM Insmed Incorporated
Stock · NasdaqGS · United States · Healthcare · US4576693075
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Insmed Incorporated, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
114.41 USD
+5.19%
52-week range
90.39 – 212.75
Dividend yield—
Market cap25.1B
NowoTrade score
27 Grade A
Price history
Daily prices in USD.
Updated 07 Nov 2026 10:21. Information, not advice.
Results
Next results
18 Feb 2027
in 103 days · 08:00 · estimate -0.33
Last results
-0.46 vs -0.37 estimated
29 Oct 2026 · Miss -23.7%
Beat the estimate
3 of 12
9 missed · 0 in line
Average surprise
-6.4%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 18 Feb 2027 08:00 | -0.33 | — | — | Upcoming |
| 29 Oct 2026 07:00 | -0.37 | -0.46 | -23.7% | Miss |
| 06 Aug 2026 07:00 | -0.68 | -0.06 | +91.2% | Beat |
| 07 May 2026 07:00 | -1.00 | -0.76 | +23.9% | Beat |
| 19 Feb 2026 07:00 | -1.17 | -1.54 | -31.9% | Miss |
| 30 Oct 2025 07:00 | -1.37 | -1.75 | -27.8% | Miss |
| 07 Aug 2025 07:00 | -1.31 | -1.70 | -29.6% | Miss |
| 08 May 2025 06:00 | -1.36 | -1.42 | -4.2% | Miss |
| 20 Feb 2025 07:00 | -1.16 | -1.32 | -13.3% | Miss |
| 31 Oct 2024 07:00 | -1.25 | -1.27 | -1.9% | Miss |
| 08 Aug 2024 07:00 | -1.23 | -1.94 | -58.2% | Miss |
| 09 May 2024 07:00 | -1.20 | -1.06 | +11.5% | Beat |
| 22 Feb 2024 07:00 | -1.13 | -1.28 | -13.3% | Miss |
| 26 Oct 2023 07:00 | -1.11 | -1.11 | +0.2% | In line |
| 03 Aug 2023 07:00 | -1.12 | -1.78 | -58.9% | Miss |
| 04 May 2023 07:00 | -1.10 | -1.17 | -6.4% | Miss |
| 23 Feb 2023 07:00 | -1.02 | -1.21 | -18.2% | Miss |
| 27 Oct 2022 07:00 | -0.87 | -1.09 | -24.9% | Miss |
| 04 Aug 2022 07:00 | -0.89 | -0.80 | +10.6% | Beat |
| 05 May 2022 07:00 | -0.87 | -0.80 | +8.1% | Beat |
| 17 Feb 2022 07:00 | -0.86 | -0.95 | -10.2% | Miss |
| 28 Oct 2021 07:00 | -0.78 | -0.96 | -23.1% | Miss |
| 05 Aug 2021 07:00 | -0.88 | -0.91 | -2.7% | Miss |
| 06 May 2021 07:00 | -0.96 | -0.89 | +7.1% | Beat |
| 25 Feb 2021 07:00 | -0.68 | -1.00 | -46.7% | Miss |
| 29 Oct 2020 07:00 | -0.59 | -0.63 | -5.9% | Miss |
| 06 Aug 2020 07:00 | -0.62 | -0.64 | -3.2% | Miss |
| 30 Apr 2020 07:00 | -0.72 | -0.74 | -2.4% | Miss |
| 25 Feb 2020 07:00 | -0.56 | -0.59 | -6.3% | Miss |
| 30 Oct 2019 07:00 | -0.67 | -0.68 | -1.5% | Miss |
| 01 Aug 2019 07:00 | -0.86 | -0.81 | +6.2% | Beat |
| 07 May 2019 07:00 | -1.00 | -0.96 | +3.6% | Beat |
| 22 Feb 2019 07:00 | -1.03 | -1.19 | -15.4% | Miss |
| 30 Oct 2018 07:00 | -1.06 | -1.14 | -7.2% | Miss |
| 02 Aug 2018 07:00 | -1.06 | -1.00 | +6.1% | Beat |
| 02 May 2018 07:00 | -0.96 | -0.87 | +10.0% | Beat |
| 23 Feb 2018 07:00 | -0.67 | -0.85 | -26.6% | Miss |
| 02 Nov 2017 07:00 | -0.70 | -0.69 | +1.4% | Beat |
| 03 Aug 2017 07:00 | -0.63 | -0.72 | -14.3% | Miss |
| 03 May 2017 08:00 | -0.60 | -0.60 | +0.3% | In line |
| 23 Feb 2017 08:00 | -0.86 | -1.10 | -27.2% | Miss |
| 03 Nov 2016 08:00 | -0.60 | -0.61 | -2.3% | Miss |
| 04 Aug 2016 08:00 | -0.56 | -0.59 | -6.0% | Miss |
| 05 May 2016 08:00 | -0.56 | -0.54 | +4.4% | Beat |
| 25 Feb 2016 08:00 | -0.49 | -0.51 | -4.0% | Miss |
| 06 Nov 2015 08:00 | -0.48 | -0.50 | -4.7% | Miss |
| 06 Aug 2015 07:00 | -0.50 | -0.47 | +5.1% | Beat |
| 07 May 2015 08:00 | -0.50 | -0.55 | -10.4% | Miss |
| 27 Feb 2015 08:00 | -0.55 | -0.36 | +34.9% | Beat |
| 06 Nov 2014 07:00 | -0.47 | -0.54 | -15.3% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 606.4M | +66.7% | -1.3B | -210.5% | -6.42 | -15.3% | -967.6M |
| 2024 | 363.7M | +19.2% | -913.8M | -251.2% | -5.57 | -4.3% | -705.8M |
| 2023 | 305.2M | +24.4% | -749.6M | -245.6% | -5.34 | -36.6% | -549.5M |
| 2022 | 245.4M | — | -481.5M | -196.3% | -3.91 | — | -410.3M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 06 Nov 2026 | 108.57 | 114.65 | 107.29 | 114.41 | +5.19% | 3,379,700 | |
| 05 Nov 2026 | 109.40 | 109.98 | 106.16 | 108.76 | -1.13% | 2,616,000 | |
| 04 Nov 2026 | 106.85 | 110.81 | 102.69 | 110.00 | +5.32% | 4,944,200 | |
| 03 Nov 2026 | 109.31 | 111.11 | 104.25 | 104.44 | -4.46% | 6,216,000 | |
| 02 Nov 2026 | 112.68 | 113.05 | 109.22 | 109.31 | -2.90% | 4,240,500 | |
| 30 Oct 2026 | 113.60 | 116.37 | 111.97 | 112.58 | +0.89% | 5,184,500 | |
| 29 Oct 2026 | 110.00 | 114.51 | 103.78 | 111.59 | +15.06% | 11,219,400 | |
| 28 Oct 2026 | 94.01 | 97.92 | 93.86 | 96.98 | +2.13% | 4,647,100 | |
| 27 Oct 2026 | 93.33 | 96.37 | 92.87 | 94.96 | +1.75% | 3,349,200 | |
| 26 Oct 2026 | 93.44 | 94.34 | 92.96 | 93.33 | -0.06% | 3,379,900 | |
| 23 Oct 2026 | 94.12 | 94.64 | 92.63 | 93.39 | -1.76% | 3,414,100 | |
| 22 Oct 2026 | 93.50 | 95.59 | 93.33 | 95.06 | +1.08% | 3,099,600 | |
| 21 Oct 2026 | 95.08 | 97.09 | 93.80 | 94.04 | -1.70% | 2,970,400 | |
| 20 Oct 2026 | 95.44 | 97.20 | 94.60 | 95.67 | +0.40% | 2,612,500 | |
| 19 Oct 2026 | 96.27 | 97.88 | 94.38 | 95.29 | -1.02% | 2,723,500 | |
| 16 Oct 2026 | 98.70 | 99.00 | 96.05 | 96.27 | -2.96% | 2,396,400 | |
| 15 Oct 2026 | 99.26 | 100.72 | 97.90 | 99.21 | +1.45% | 3,346,600 | |
| 14 Oct 2026 | 97.39 | 98.00 | 95.76 | 97.79 | +1.03% | 2,736,400 | |
| 13 Oct 2026 | 98.18 | 99.73 | 96.54 | 96.79 | -1.80% | 2,161,100 | |
| 12 Oct 2026 | 98.82 | 100.31 | 98.33 | 98.56 | -2.03% | 1,696,000 | |
| 09 Oct 2026 | 100.52 | 101.82 | 99.15 | 100.60 | +0.12% | 2,474,300 | |
| 08 Oct 2026 | 100.66 | 101.06 | 96.68 | 100.48 | -1.24% | 5,251,800 | |
| 07 Oct 2026 | 103.87 | 104.80 | 101.60 | 101.74 | -3.32% | 3,164,000 | |
| 06 Oct 2026 | 103.97 | 107.87 | 101.32 | 105.23 | +1.35% | 3,685,700 | |
| 05 Oct 2026 | 105.50 | 108.75 | 101.65 | 103.83 | -6.56% | 5,394,700 |
Page 1 of 51
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Insmed to Present at November and December 2026 Investor Conferences (opens in a new tab) 04 Nov 2026 12:00
- HC Wainwright & Co. Assumes Insmed at Buy, Announces Price Target of $220 (opens in a new tab) Benzinga · 04 Nov 2026 08:24
- Guggenheim Maintains Buy on Insmed, Lowers Price Target to $201 (opens in a new tab) Benzinga · 02 Nov 2026 10:13
- Insmed (INSM) Lifts Guidance After Earnings As Fair Value Debate Heats Up (opens in a new tab) Simply Wall St. · 31 Oct 2026 16:09
- Insmed (INSM) Begins BRINSUPRI Sales In Japan (opens in a new tab) Simply Wall St. · 31 Oct 2026 01:17
- Insmed Incorporated (INSM) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 30 Oct 2026 21:48
- INSM Q3 Earnings Miss, Stock Soars on Sales Beat & Raised Guidance (opens in a new tab) Zacks · 30 Oct 2026 13:29
- Insmed Incorporated Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 30 Oct 2026 12:30
- Why Did Insmed Stock Jump? (opens in a new tab) Trefis · 30 Oct 2026 11:15
- Insmed Soars 12% on $400 Million Brinsupri Quarter as U.S. Launch “Continues to Exceed Expectations” (opens in a new tab) TIKR · 29 Oct 2026 18:40
- What Insmed (INSM) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 29 Oct 2026 18:14
- Insmed (INSM) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 29 Oct 2026 18:13
- Insmed (INSM) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (opens in a new tab) Zacks · 29 Oct 2026 12:30
- Insmed (INSM) Reports Q3 Loss, Tops Revenue Estimates (opens in a new tab) Zacks · 29 Oct 2026 11:35
- Insmed: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 29 Oct 2026 11:06
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 108.76 USD
- Market cap
- 25.1B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 25.0 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 0.0 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 2.0 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 0.0 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 10.0 / 10 |
|
- Score capped at 60: free cash flow was negative in two of the last three years
- Thin interest cover: operating profit is only -12.8× the interest
- The last full year was a loss
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 12 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (forward) | 174.81× | Weak | 14.98× |
| Price / book | 34.55× | Weak | 3.94× |
| Price / sales | 16.52× | Weak | 3.37× |
| EV / EBITDA | -38.37× | Weak | 12.96× |
| Free cash flow yield | -1.8% | Weak | 2.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 84.4% | Good | 59.2% |
| Operating margin | -15.6% | Weak | 7.4% |
| Net margin | -39.9% | Weak | 3.4% |
| Return on equity | -72.5% | Weak | 5.7% |
| Return on assets | -17.3% | Weak | 3.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 35.2% | Good | 10.8% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 1.01× | Fair | 0.46× |
| Interest cover | -12.82× | Weak | 3.26× |
| Current ratio | 2.86× | Good | 2.35× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow INSM and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.